OptimizeRx (OPRX) Other financing activities (2010 - 2022)

OptimizeRx's Other financing activities history runs 9 years deep, the most recent figure standing at $4.3 million for Q3 2022.

• In Q3 2022, Other financing activities rose 324.33% year-over-year to $4.3 million; the TTM figure through Sep 2022 stood at $12.5 million (up 317.05% YoY), while the FY2018 annual figure was $1.9 million, changed N/A from the prior year.
• Other financing activities came in at $4.3 million for Q3 2022 at OptimizeRx, up from $4.0 million in the prior quarter.
• In the past five years, Other financing activities ranged from a high of $4.3 million in Q3 2022 to a low of $408087.0 in Q2 2019.
• A 5-year average of $1.4 million and a median of $754512.0 in 2020 frame the typical range for Other financing activities.
• Across the five-year window, Other financing activities dropped 22.84% in 2021 and soared 445.23% in 2022, its largest moves.
• OptimizeRx's Other financing activities stood at $1.0 million in 2018, then sank by 54.34% to $469539.0 in 2019, then surged by 34.48% to $631453.0 in 2020, then jumped by 59.63% to $1.0 million in 2021, then jumped by 324.33% to $4.3 million in 2022.
• According to Business Quant data, Other financing activities over the past three periods registered $4.3 million, $4.0 million, and $3.2 million for Q3 2022, Q2 2022, and Q1 2022 respectively.

Peer Comparison